Amy J. Jones

539 total citations
14 papers, 356 citations indexed

About

Amy J. Jones is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Organic Chemistry. According to data from OpenAlex, Amy J. Jones has authored 14 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Public Health, Environmental and Occupational Health and 6 papers in Organic Chemistry. Recurrent topics in Amy J. Jones's work include Trypanosoma species research and implications (11 papers), Research on Leishmaniasis Studies (7 papers) and Synthesis and Biological Evaluation (5 papers). Amy J. Jones is often cited by papers focused on Trypanosoma species research and implications (11 papers), Research on Leishmaniasis Studies (7 papers) and Synthesis and Biological Evaluation (5 papers). Amy J. Jones collaborates with scholars based in Australia, Switzerland and China. Amy J. Jones's co-authors include Vicky M. Avery, Melissa L. Sykes, Jonathan B. Baell, Brad E. Sleebs, Todd Shelper, Rebecca Lang, Moana Simpson, Sally‐Ann Poulsen, Sandra Duffy and Subathdrage D.M. Sumanadasa and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and European Journal of Medicinal Chemistry.

In The Last Decade

Amy J. Jones

14 papers receiving 352 citations

Peers

Countries citing papers authored by Amy J. Jones

Since Specialization

Citations

This map shows the geographic impact of Amy J. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy J. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy J. Jones more than expected).

Fields of papers citing papers by Amy J. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy J. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy J. Jones. The network helps show where Amy J. Jones may publish in the future.

Co-authorship network of co-authors of Amy J. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Amy J. Jones. A scholar is included among the top collaborators of Amy J. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy J. Jones. Amy J. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Investigation of thiazolyl–benzothiophenamides as potential agents for African sleeping sickness 2020 ·RSC Medicinal Chemistry ·(unknown), (unknown), Paul A. Keller, Amy J. Jones, Melissa L. Sykes, Marcel Kaiser, Jonathan B. Baell, Vicky M. Avery, Christopher J. T. Hyland	2
2	Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity 2018 ·Journal of Medicinal Chemistry ·Angie M. Jarrad, Ang Chee Wei, Anjan Debnath, (unknown), Kyra Woods, Lendl Tan, Melissa L. Sykes, Amy J. Jones, Ruby Pelingon, Mark S. Butler, Vicky M. Avery, Nicholas P. West, Tomislav Karoli, Mark A. T. Blaskovich, Matthew A. Cooper	20
3	Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery 2017 ·Antimicrobial Agents and Chemotherapy ·Sandra Duffy, Melissa L. Sykes, Amy J. Jones, Todd Shelper, Moana Simpson, Rebecca Lang, Sally‐Ann Poulsen, Brad E. Sleebs, Vicky M. Avery	96
4	Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway 2016 ·Parasites & Vectors ·(unknown), Leonardo Lucantoni, Melissa L. Sykes, Amy J. Jones, John P. Holleran, Kevin J. Saliba, Vicky M. Avery	14
5	Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide 2016 ·Metabolomics ·(unknown), Cameron J. Nowell, Amy J. Jones, Lori Ferrins, (unknown), Jennifer Riley, Raphaël Rahmani, Kevin D. Read, Malcolm J. McConville, Vicky M. Avery, Jonathan B. Baell, Darren J. Creek	26
6	Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites 2015 ·International Journal for Parasitology Drugs and Drug Resistance ·Jessica A. Engel, Amy J. Jones, Vicky M. Avery, Subathdrage D.M. Sumanadasa, Susanna S. Ng, David P. Fairlie, Tina S. Skinner‐Adams, Katherine T. Andrews	71
7	6-Arylpyrazine-2-carboxamides: A New Core for Trypanosoma brucei Inhibitors 2015 ·Journal of Medicinal Chemistry ·Raphaël Rahmani, (unknown), Amy J. Jones, Lori Ferrins, (unknown), Melissa L. Sykes, Vicky M. Avery, Karen L. White, Eileen Ryan, Marcel Kaiser, Susan A. Charman, Jonathan B. Baell	13
8	Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis 2015 ·Antimicrobial Agents and Chemotherapy ·Amy J. Jones, Marcel Kaiser, Vicky M. Avery	4
9	Design and Synthesis of a Screening Library Using the Natural Product Scaffold 3-Chloro-4-hydroxyphenylacetic Acid 2015 ·Journal of Natural Products ·Rohitesh Kumar, Martin C. Sadowski, (unknown), Colleen C. Nelson, Amy J. Jones, John P. Holleran, Vicky M. Avery, Peter C. Healy, Rohan A. Davis	11
10	Pyridyl Benzamides as a Novel Class of Potent Inhibitors for the KinetoplastidTrypanosoma brucei 2014 ·Journal of Medicinal Chemistry ·Lori Ferrins, Michelle Gazdik, Raphaël Rahmani, Swapna Varghese, Melissa L. Sykes, Amy J. Jones, Vicky M. Avery, Karen L. White, Eileen Ryan, Susan A. Charman, Marcel Kaiser, Christel A. S. Bergström, Jonathan B. Baell	52
11	Facile Synthesis and Preliminary Structure–Activity Analysis of New Sulfonamides Against Trypanosoma brucei 2014 ·ACS Medicinal Chemistry Letters ·Adel A. Rashad, Amy J. Jones, Vicky M. Avery, Jonathan B. Baell, Paul A. Keller	12
12	Synthesis and evaluation of phenoxymethylbenzamide analogues as anti-trypanosomal agents 2014 ·MedChemComm ·(unknown), Emma E. Watson, Melissa L. Sykes, Amy J. Jones, Jonathan B. Baell, Marcel Kaiser, Vicky M. Avery, Richard J. Payne	5
13	3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis 2013 ·European Journal of Medicinal Chemistry ·Lori Ferrins, Raphaël Rahmani, Melissa L. Sykes, Amy J. Jones, Vicky M. Avery, Eliott Teston, (unknown), (unknown), Jason A. Smith, Christopher J. T. Hyland, Karen L. White, Eileen Ryan, Michael Campbell, Susan A. Charman, Marcel Kaiser, Jonathan B. Baell	23
14	Whole-organism high-throughput screening againstTrypanosoma brucei brucei 2013 ·Expert Opinion on Drug Discovery ·Amy J. Jones, Vicky M. Avery	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact